CD4 and cancer: The frequency of CD4+ lymphocytes with a memory phenotype is reported to significantly increase in patients with tumor free lymph node, and the generation of memory response against tumor antigens and may prevent tumor relapse in patients with different cancers, which predict a longer survival [31, 32].